[ad_1]
According to the Centers for Disease Control and Prevention, more than 37 million people in the United States have diabetes. This is just over 11% of the total population.
A person with diabetes does not produce enough insulin or any insulin at all. People with this disease should monitor their blood sugar regularly. This has traditionally been done with glucometers, which diabetics use to prick their fingers over and over again to get drops of blood. But over the past decade, technology like continuous glucose monitoring has been on the rise.
Abbott And dexcom They are the two most dominant players in the space. Both companies have experienced exponential growth.
This technology is also being marketed through various health and wellness applications as many companies see benefits for those without diabetes.
CNBC spoke with both Abbott and Dexcom about the technology inside CGMs and how they see it expanding.
Watch the video to learn more.
[ad_2]
